Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
, 34 (10), 1496-503

Impact of Infection on the Prognosis of Critically Ill Cirrhotic Patients: Results From a Large Worldwide Study

Collaborators, Affiliations
Comparative Study

Impact of Infection on the Prognosis of Critically Ill Cirrhotic Patients: Results From a Large Worldwide Study

Thierry Gustot et al. Liver Int.

Abstract

Background: Infections are a leading cause of death in patients with advanced cirrhosis, but there are relatively few data on the epidemiology of infection in intensive care unit (ICU) patients with cirrhosis.

Aims: We used data from the Extended Prevalence of Infection in Intensive Care (EPIC) II 1-day point-prevalence study to better define the characteristics of infection in these patients.

Methods: We compared characteristics, including occurrence and types of infections in non-cirrhotic and cirrhotic patients who had not undergone liver transplantation.

Results: The EPIC II database includes 13,796 adult patients from 1265 ICUs: 410 of the patients had cirrhosis. The prevalence of infection was higher in cirrhotic than in non-cirrhotic patients (59 vs. 51%, P < 0.01). The lungs were the most common site of infection in all patients, but abdominal infections were more common in cirrhotic than in non-cirrhotic patients (30 vs. 19%, P < 0.01). Infected cirrhotic patients more often had Gram-positive (56 vs. 47%, P < 0.05) isolates than did infected non-cirrhotic patients. Methicillin-resistant Staphylococcus aureus (MRSA) was more frequent in cirrhotic patients. The hospital mortality rate of cirrhotic patients was 42%, compared to 24% in the non-cirrhotic population (P < 0.001). Severe sepsis and septic shock were associated with higher in-hospital mortality rates in cirrhotic than in non-cirrhotic patients (41% and 71% vs. 30% and 49%, respectively, P < 0.05).

Conclusions: Infection is more common in cirrhotic than in non-cirrhotic ICU patients and more commonly caused by Gram-positive organisms, including MRSA. Infection in patients with cirrhosis was associated with higher mortality rates than in non-cirrhotic patients.

Keywords: cirrhosis; infection; mortality; organ failure.

Similar articles

See all similar articles

Cited by 21 articles

  • Acute-on-chronic liver failure: Objective admission and support criteria in the intensive care unit.
    Dong V, Karvellas CJ. Dong V, et al. JHEP Rep. 2019 Mar 18;1(1):44-52. doi: 10.1016/j.jhepr.2019.02.005. eCollection 2019 May. JHEP Rep. 2019. PMID: 32039351 Free PMC article. Review.
  • Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites.
    Simbrunner B, Röthenbacher A, Haslacher H, Bauer D, Chromy D, Bucsics T, Schwabl P, Paternostro R, Scheiner B, Trauner M, Mandorfer M, Schwarzinger I, Reiberger T. Simbrunner B, et al. United European Gastroenterol J. 2019 Jun;7(5):651-661. doi: 10.1177/2050640619843000. Epub 2019 Apr 5. United European Gastroenterol J. 2019. PMID: 31210943 Free PMC article.
  • Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.
    Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party.. Sarin SK, et al. Hepatol Int. 2019 Jul;13(4):353-390. doi: 10.1007/s12072-019-09946-3. Epub 2019 Jun 6. Hepatol Int. 2019. PMID: 31172417 Free PMC article.
  • Causes and Consequences of Innate Immune Dysfunction in Cirrhosis.
    Irvine KM, Ratnasekera I, Powell EE, Hume DA. Irvine KM, et al. Front Immunol. 2019 Feb 25;10:293. doi: 10.3389/fimmu.2019.00293. eCollection 2019. Front Immunol. 2019. PMID: 30873165 Free PMC article. Review.
  • Invasive pulmonary aspergillosis in cirrhotic patients: analysis of a 10-year clinical experience.
    Levesque E, Ait-Ammar N, Dudau D, Clavieras N, Feray C, Foulet F, Botterel F. Levesque E, et al. Ann Intensive Care. 2019 Feb 18;9(1):31. doi: 10.1186/s13613-019-0502-2. Ann Intensive Care. 2019. PMID: 30778699 Free PMC article.
See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback